The risk of acute coronary syndrome in rheumatoid arthritis in relation to tumour necrosis factor inhibitors and the risk in the general population: a national cohort study

Lotta Ljung; Johan Askling; Solbritt Rantapää-Dahlqvist; Lennart Jacobsson;

doi:10.1186/ar4584

The risk of acute coronary syndrome in rheumatoid arthritis in relation to tumour necrosis factor inhibitors and the risk in the general population: a national cohort study

Arthritis Research & Therapy ◽

10.1186/ar4584 ◽

2014 ◽

Vol 16 (3) ◽

pp. R127 ◽

Cited By ~ 43

Author(s):

Lotta Ljung ◽

Johan Askling ◽

Solbritt Rantapää-Dahlqvist ◽

Lennart Jacobsson ◽

Keyword(s):

Rheumatoid Arthritis ◽

Acute Coronary Syndrome ◽

Cohort Study ◽

General Population ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Coronary Syndrome ◽

Tumour Necrosis Factor Inhibitors ◽

National Cohort ◽

Necrosis Factor

Download Full-text

Biologic Agents Reduce Cardiovascular Events in Rheumatoid Arthritis Not Responsive to Tumour Necrosis Factor Inhibitors: A National Cohort Study

Canadian Journal of Cardiology ◽

10.1016/j.cjca.2020.01.003 ◽

2020 ◽

Vol 36 (11) ◽

pp. 1739-1746 ◽

Cited By ~ 1

Author(s):

Ming-Jer Hsieh ◽

Cheng-Hung Lee ◽

Ming-Lung Tsai ◽

Chang-Fu Kao ◽

Wen-Ching Lan ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Cohort Study ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Cardiovascular Events ◽

Biologic Agents ◽

Tumour Necrosis Factor Inhibitors ◽

National Cohort ◽

Necrosis Factor

Download Full-text

Insensitivity versus poor response to tumour necrosis factor inhibitors in rheumatoid arthritis: a retrospective cohort study

Arthritis Research & Therapy ◽

10.1186/s13075-020-2122-5 ◽

2020 ◽

Vol 22 (1) ◽

Author(s):

Sae Ochi ◽

Kazuyoshi Saito ◽

Fumitaka Mizoguchi ◽

Shigeaki Kato ◽

Yoshiya Tanaka

Keyword(s):

Rheumatoid Arthritis ◽

Cohort Study ◽

Tumour Necrosis Factor ◽

Retrospective Cohort Study ◽

Tumour Necrosis ◽

Retrospective Cohort ◽

Poor Response ◽

Tumour Necrosis Factor Inhibitors ◽

Necrosis Factor

Download Full-text

EuroQol-5 dimensions utility gain according to British and Swedish preference sets in rheumatoid arthritis treated with abatacept, rituximab, tocilizumab, or tumour necrosis factor inhibitors: a prospective cohort study from southern Sweden

Arthritis Research & Therapy ◽

10.1186/s13075-016-0950-0 ◽

2016 ◽

Vol 18 (1) ◽

Cited By ~ 6

Author(s):

Anders Gülfe ◽

Johan K. Wallman ◽

Lars Erik Kristensen

Keyword(s):

Rheumatoid Arthritis ◽

Cohort Study ◽

Tumour Necrosis Factor ◽

Prospective Cohort Study ◽

Prospective Cohort ◽

Tumour Necrosis ◽

Southern Sweden ◽

Tumour Necrosis Factor Inhibitors ◽

Utility Gain ◽

Necrosis Factor

Download Full-text

Faculty Opinions recommendation of The effectiveness of leflunomide as a co-therapy of tumour necrosis factor inhibitors in rheumatoid arthritis: a population-based study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1104777.560749 ◽

2008 ◽

Author(s):

Geoff Littlejohn

Keyword(s):

Rheumatoid Arthritis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Population Based ◽

Population Based Study ◽

Tumour Necrosis Factor Inhibitors ◽

Necrosis Factor

Download Full-text

Immediate treatment with tumour necrosis factor inhibitors in synthetic disease-modifying anti-rheumatic drugs-naïve patients with rheumatoid arthritis: results of a modified Italian Expert Consensus

Rheumatology ◽

10.1093/rheumatology/key076 ◽

2018 ◽

Vol 57 (Supplement_7) ◽

pp. vii32-vii41

Author(s):

Alessandra Bortoluzzi ◽

Guido Valesini ◽

Salvatore D’Angelo ◽

Bruno Frediani ◽

Laura Bazzichi ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Expert Consensus ◽

Tumour Necrosis Factor Inhibitors ◽

Disease Modifying ◽

Necrosis Factor

Download Full-text

Malignancy risk in Australian rheumatoid arthritis patients treated with anti-tumour necrosis factor therapy: an update from the Australian Rheumatology Association Database (ARAD) prospective cohort study

BMC Rheumatology ◽

10.1186/s41927-018-0050-7 ◽

2019 ◽

Vol 3 (1) ◽

Cited By ~ 4

Author(s):

Margaret P. Staples ◽

Lyn March ◽

Catherine Hill ◽

Marissa Lassere ◽

Rachelle Buchbinder

Keyword(s):

Rheumatoid Arthritis ◽

Cohort Study ◽

Tumour Necrosis Factor ◽

Prospective Cohort Study ◽

Prospective Cohort ◽

Tumour Necrosis ◽

Malignancy Risk ◽

Factor Therapy ◽

Necrosis Factor

Download Full-text

Tumour necrosis factor inhibitors and risk of serious infection in rheumatoid arthritis

International Journal of Rheumatic Diseases ◽

10.1111/j.1756-185x.2009.01457.x ◽

2010 ◽

Vol 13 (1) ◽

pp. 12-26 ◽

Cited By ~ 15

Author(s):

Veera S. KATIKIREDDI ◽

Samuel L. WHITTLE ◽

Catherine L. HILL

Keyword(s):

Rheumatoid Arthritis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Tumour Necrosis Factor Inhibitors ◽

Serious Infection ◽

Necrosis Factor

Download Full-text

Comparison of tocilizumab and tumour necrosis factor inhibitors in rheumatoid arthritis: a retrospective analysis of 1603 patients managed in routine clinical practice

Clinical Rheumatology ◽

10.1007/s10067-015-2879-0 ◽

2015 ◽

Vol 34 (4) ◽

pp. 673-681 ◽

Cited By ~ 21

Author(s):

Marina Backhaus ◽

Jörg Kaufmann ◽

Constanze Richter ◽

Siegfried Wassenberg ◽

Anne-Eve Roske ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Clinical Practice ◽

Retrospective Analysis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Routine Clinical Practice ◽

Tumour Necrosis Factor Inhibitors ◽

Necrosis Factor

Download Full-text

AB0526 Sustained efficacy responses and a consistent safety profile with rituximab repeat treatment over 5 years in patients with rheumatoid arthritis and an inadequate response to tumour necrosis factor inhibitors in the reflex study:

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2012-eular.526 ◽

2013 ◽

Vol 71 (Suppl 3) ◽

pp. 668.6-668

Author(s):

E. Keystone ◽

S.B. Cohen ◽

P. Emery ◽

J.M. Kremer ◽

M. Dougados ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Tumour Necrosis Factor ◽

Safety Profile ◽

Tumour Necrosis ◽

Inadequate Response ◽

Sustained Efficacy ◽

Repeat Treatment ◽

Tumour Necrosis Factor Inhibitors ◽

Necrosis Factor

Download Full-text

Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trial

The Lancet ◽

10.1016/s0140-6736(12)61424-x ◽

2013 ◽

Vol 381 (9865) ◽

pp. 451-460 ◽

Cited By ~ 393

Author(s):

Gerd R Burmester ◽

Ricardo Blanco ◽

Christina Charles-Schoeman ◽

Jürgen Wollenhaupt ◽

Cristiano Zerbini ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Active Rheumatoid Arthritis ◽

Inadequate Response ◽

Phase 3 ◽

Tumour Necrosis Factor Inhibitors ◽

Necrosis Factor

Download Full-text